Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1576, 2007-01, pp. : 17-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. :
Access to resources
Recommend
Efalizumab a CLEAR winner for psoriasis
Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. :
Efalizumab: durable benefits in plaque psoriasis
Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. :
Efalizumab withdrawal: Rebound psoriasis, treated with infliximab then efalizumab: case report
Reactions Weekly, Vol. 1, Iss. 1240, 2009-01 ,pp. :
Adalimumab/efalizumab/infliximab: Psoriasis: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. :